Moreover, the CD1d ligand alpha-galactosylceramide (αGalCer) used as a natural killer (NK) T cell adjuvant to boost vaccine responses had the paradoxical effect of reducing primary CD8 T cell responses due to IDO induction, even though αGalCer boosted long-term protective memory to influenza vaccination [41]. Here, CD8A is linked to influenza.